124 related articles for article (PubMed ID: 26096657)
21. Physico-chemical and toxicological characterization of iron-containing albumin nanoparticles as platforms for medical imaging.
Rosenberger I; Schmithals C; Vandooren J; Bianchessi S; Milani P; Locatelli E; Israel LL; Hübner F; Matteoli M; Lellouche JP; Franchini MC; Passoni L; Scanziani E; Opdenakker G; Piiper A; Kreuter J
J Control Release; 2014 Nov; 194():130-7. PubMed ID: 25173842
[TBL] [Abstract][Full Text] [Related]
22. Design of water-based ferrofluids as contrast agents for magnetic resonance imaging.
Casula MF; Corrias A; Arosio P; Lascialfari A; Sen T; Floris P; Bruce IJ
J Colloid Interface Sci; 2011 May; 357(1):50-5. PubMed ID: 21345440
[TBL] [Abstract][Full Text] [Related]
23. Preventing corona effects: multiphosphonic acid poly(ethylene glycol) copolymers for stable stealth iron oxide nanoparticles.
Torrisi V; Graillot A; Vitorazi L; Crouzet Q; Marletta G; Loubat C; Berret JF
Biomacromolecules; 2014 Aug; 15(8):3171-9. PubMed ID: 25046557
[TBL] [Abstract][Full Text] [Related]
24. Visualization of vascular inflammation in the atherosclerotic mouse by ultrasmall superparamagnetic iron oxide vascular cell adhesion molecule-1-specific nanoparticles.
Michalska M; Machtoub L; Manthey HD; Bauer E; Herold V; Krohne G; Lykowsky G; Hildenbrand M; Kampf T; Jakob P; Zernecke A; Bauer WR
Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2350-7. PubMed ID: 22879583
[TBL] [Abstract][Full Text] [Related]
25. Hyaluronic acid immobilized magnetic nanoparticles for active targeting and imaging of macrophages.
Kamat M; El-Boubbou K; Zhu DC; Lansdell T; Lu X; Li W; Huang X
Bioconjug Chem; 2010 Nov; 21(11):2128-35. PubMed ID: 20977242
[TBL] [Abstract][Full Text] [Related]
26. Comparison of in vivo targeting ability between cRGD and collagen-targeting peptide conjugated nano-carriers for atherosclerosis.
Kim M; Sahu A; Kim GB; Nam GH; Um W; Shin SJ; Jeong YY; Kim IS; Kim K; Kwon IC; Tae G
J Control Release; 2018 Jan; 269():337-346. PubMed ID: 29175140
[TBL] [Abstract][Full Text] [Related]
27. Facile preparation of zwitterion-stabilized superparamagnetic iron oxide nanoparticles (ZSPIONs) as an MR contrast agent for in vivo applications.
Kim D; Chae MK; Joo HJ; Jeong IH; Cho JH; Lee C
Langmuir; 2012 Jun; 28(25):9634-9. PubMed ID: 22607014
[TBL] [Abstract][Full Text] [Related]
28. Nanoparticles functionalised with an anti-platelet human antibody for in vivo detection of atherosclerotic plaque by magnetic resonance imaging.
Jacobin-Valat MJ; Laroche-Traineau J; Larivière M; Mornet S; Sanchez S; Biran M; Lebaron C; Boudon J; Lacomme S; Cérutti M; Clofent-Sanchez G
Nanomedicine; 2015 May; 11(4):927-37. PubMed ID: 25684334
[TBL] [Abstract][Full Text] [Related]
29. In vivo MR imaging of bone marrow cells trafficking to atherosclerotic plaques.
Qiu B; Gao F; Walczak P; Zhang J; Kar S; Bulte JW; Yang X
J Magn Reson Imaging; 2007 Aug; 26(2):339-43. PubMed ID: 17623878
[TBL] [Abstract][Full Text] [Related]
30. Cleaved iron oxide nanoparticles as T2 contrast agents for magnetic resonance imaging.
Jeon SL; Chae MK; Jang EJ; Lee C
Chemistry; 2013 Mar; 19(13):4217-22. PubMed ID: 23345158
[TBL] [Abstract][Full Text] [Related]
31. [The progress of nuclear medicine and magnetic resonance molecular imaging of atherosclerotic vulnerable plaques].
Zhao ZM; Qin SC
Sheng Li Ke Xue Jin Zhan; 2011 Apr; 42(2):86-90. PubMed ID: 21770253
[TBL] [Abstract][Full Text] [Related]
32. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.
Gupta AK; Naregalkar RR; Vaidya VD; Gupta M
Nanomedicine (Lond); 2007 Feb; 2(1):23-39. PubMed ID: 17716188
[TBL] [Abstract][Full Text] [Related]
33. Targeting Nanostrategies for Imaging of Atherosclerosis.
Costagliola di Polidoro A; Grassia A; De Sarno F; Bevilacqua P; Mollo V; Romano E; Di Taranto MD; Fortunato G; Bracale UM; Tramontano L; Diomaiuti TC; Torino E
Contrast Media Mol Imaging; 2021; 2021():6664471. PubMed ID: 33880112
[TBL] [Abstract][Full Text] [Related]
34. Hyaluronic Acid-Functionalized Gadolinium Doped Iron Oxide Nanoparticles for Atherosclerosis-Targeted Mr Imaging.
Yu M; Niu Y; Zhou D; Jiang R; Zhang L; Ju H; Gong A; Zou S; Zhang M; Du F
J Biomed Nanotechnol; 2019 Jan; 15(1):127-137. PubMed ID: 30480520
[TBL] [Abstract][Full Text] [Related]
35. Surface functionalization of single superparamagnetic iron oxide nanoparticles for targeted magnetic resonance imaging.
Amstad E; Zurcher S; Mashaghi A; Wong JY; Textor M; Reimhult E
Small; 2009 Jun; 5(11):1334-42. PubMed ID: 19242944
[TBL] [Abstract][Full Text] [Related]
36. Protein corona and phospholipase activity drive selective accumulation of nanomicelles in atherosclerotic plaques.
Lechuga-Vieco AV; Groult H; Pellico J; Mateo J; Enríquez JA; Ruiz-Cabello J; Herranz F
Nanomedicine; 2018 Apr; 14(3):643-650. PubMed ID: 29317346
[TBL] [Abstract][Full Text] [Related]
37. Fabrication of contrast agents for magnetic resonance imaging from polymer-brush-afforded iron oxide magnetic nanoparticles prepared by surface-initiated living radical polymerization.
Ohno K; Mori C; Akashi T; Yoshida S; Tago Y; Tsujii Y; Tabata Y
Biomacromolecules; 2013 Oct; 14(10):3453-62. PubMed ID: 23957585
[TBL] [Abstract][Full Text] [Related]
38. Effect of surface modification on magnetization of iron oxide nanoparticle colloids.
Yuan Y; Rende D; Altan CL; Bucak S; Ozisik R; Borca-Tasciuc DA
Langmuir; 2012 Sep; 28(36):13051-9. PubMed ID: 22889238
[TBL] [Abstract][Full Text] [Related]
39. Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging.
Li J; He Y; Sun W; Luo Y; Cai H; Pan Y; Shen M; Xia J; Shi X
Biomaterials; 2014 Apr; 35(11):3666-77. PubMed ID: 24462358
[TBL] [Abstract][Full Text] [Related]
40. Animal models of atherosclerosis and magnetic resonance imaging for monitoring plaque progression.
Millon A; Canet-Soulas E; Boussel L; Fayad Z; Douek P
Vascular; 2014 Jun; 22(3):221-37. PubMed ID: 24907292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
